Atomoxetine could improve intra-individual variability in drug-naïve adults with attention-deficit/hyperactivity disorder comparably with methylphenidate: A head-to-head randomized clinical trial

Abstract

Objective:

Intra-individual variability in reaction time (IIV-RT) is common in individuals with attention-deficit/hyperactivity disorder (ADHD). It can be improved by stimulants. However, the effects of atomoxetine on IIV-RT are inconclusive. We aimed to investigate the effects of atomoxetine on IIV-RT, and directly compared its efficacy with methylphenidate in adults with ADHD.

Methods:

An 8–10 week, open-label, head-to-head, randomized clinical trial was conducted in 52 drug-naïve adults with ADHD, who were randomly assigned to two treatment groups: immediate-release methylphenidate (n=26) thrice daily (10–20 mg per dose) and atomoxetine once daily (n=26) (0.5–1.2 mg/kg/day). IIV-RT, derived from the Conners’ continuous performance test (CCPT), was represented by the Gaussian (reaction time standard error, RTSE) and ex-Gaussian models (sigma and tau). Other neuropsychological functions, including response errors and mean of reaction time, were also measured. Participants received CCPT assessments at baseline and week 8-10 (60.4±6.3 days).

Results:

We found comparable improvements in performances of CCPT between the immediate-release methylphenidate- and atomoxetine-treated groups. Both medications significantly improved IIV-RT in terms of reducing tau values with comparable efficacy. In addition, both medications significantly improved inhibitory control by reducing commission errors.

Conclusion:

Our results provide evidence to support that atomoxetine could improve IIV-RT and inhibitory control, of comparable efficacy with immediate-release methylphenidate, in drug-naïve adults with ADHD. Shared and unique mechanisms underpinning these medication effects on IIV-RT awaits further investigation.

Keywords

Adult methylphenidate atomoxetine intra-individual variability in reaction time ex-Gaussian distribution attention-deficit/hyperactivity disorder

Get full access to this article

View all access options for this article.

References

Alderson

Kasper

Hudec

. (2013) Attention-deficit/hyperactivity disorder (ADHD) and working memory in adults: a meta-analytic review. Neuropsychology 27: 287–302.

Andreou

Neale

Chen

. (2007) Reaction time performance in ADHD: improvement under fast-incentive condition and familial effects. Psychol Med 37: 1703–1715.

Araki

Ikegami

Okayama

. (2015) Improved prefrontal activity in AD/HD children treated with atomoxetine: a NIRS study. Brain Dev 37: 76–87.

Balota

Yap

(2011) Moving beyond the mean in studies of mental chronometry: the power of response time distributional analyses. Curr Dir Psychol Sci 20: 160–166.

Bedard

Stein

Halperin

. (2015) Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention-deficit/hyperactivity disorder. J Child Psychol Psychiat 56: 40–48.

Bedard

Trampush

Newcorn

. (2010) Perceptual and motor inhibition in adolescents/young adults with childhood-diagnosed ADHD. Neuropsychology 24: 424–434.

Berridge

Devilbiss

Andrzejewski

. (2006) Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiat 60: 1111–1120.

Bidwell

Willcutt

Defries

. (2007) Testing for neuropsychological endophenotypes in siblings discordant for attention-deficit/hyperactivity disorder. Biol Psychiat 62: 991–998.

Biederman

Spencer

(1999) Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiat 46: 1234–1242.

10.

Blatter

Cajochen

(2007) Circadian rhythms in cognitive performance: methodological constraints, protocols, theoretical underpinnings. Physiol Behav 90: 196–208.

11.

Boonstra

Kooij

Oosterlaan

. (2005) Does methylphenidate improve inhibition and other cognitive abilities in adults with childhood-onset ADHD? J Clin Exp Neuropsychol 27: 278–298.

12.

Bouffard

Hechtman

Minde

. (2003) The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder. Can J Psychiat 48: 546–554.

13.

Buzy

Medoff

Schweitzer

(2009) Intra-individual variability among children with ADHD on a working memory task: an ex-Gaussian approach. Child Neuropsychol 15: 441–459.

14.

Bymaster

Katner

Nelson

. (2002) Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacol 27: 699–711.

15.

Castellanos

Sonuga-Barke

Scheres

. (2005) Varieties of attention-deficit/hyperactivity disorder-related intra-individual variability. Biol Psychiat 57: 1416–1423.

16.

Chamberlain

Del Campo

Dowson

. (2007) Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. Biol Psychiat 62: 977–984.

17.

Chang

Chiu

. (2013) Father’s parenting and father-child relationship among children and adolescents with attention-deficit/hyperactivity disorder. Compr Psychiat 54: 128–140.

18.

Christakou

Murphy

Chantiluke

. (2013) Disorder-specific functional abnormalities during sustained attention in youth with Attention Deficit Hyperactivity Disorder (ADHD) and with autism. Mol Psychiat 18: 236–244.

19.

Coghill

Seth

Pedroso

. (2014) Effects of methylphenidate on cognitive functions in children and adolescents with Attention-Deficit/Hyperactivity Disorder: evidence from a systematic review and a meta-analysis. Biol Psychiat 76: 603–615.

20.

Conners

Epstein

Angold

. (2003) Continuous performance test performance in a normative epidemiological sample. J Abnorm Child Psychol 31: 555–562.

21.

Cubillo

Smith

Barrett

. (2014a) Drug-specific laterality effects on frontal lobe activation of atomoxetine and methylphenidate in attention deficit hyperactivity disorder boys during working memory. Psychol Med 44: 633–646.

22.

Cubillo

Smith

Barrett

. (2014b) Shared and drug-specific effects of atomoxetine and methylphenidate on inhibitory brain dysfunction in medication-naive ADHD boys. Cereb Cortex 24: 174–185.

23.

Epstein

Brinkman

Froehlich

. (2011) Effects of stimulant medication, incentives, and event rate on reaction time variability in children with ADHD. Neuropsychopharmacol 36: 1060–1072.

24.

Epstein

Conners

Hervey

. (2006) Assessing medication effects in the MTA study using neuropsychological outcomes. J Child Psychol Psychiat 47: 446–456.

25.

Fassbender

Zhang

Buzy

. (2009) A lack of default network suppression is linked to increased distractibility in ADHD. Brain Res 1273: 114–128.

26.

Feige

Biscaldi

Saville

. (2013) On the temporal characteristics of performance variability in attention deficit hyperactivity disorder (ADHD). PLoS One 8: e69674.

27.

Gau

Chiang

(2009) Sleep problems and disorders among adolescents with persistent and subthreshold attention-deficit/hyperactivity disorders. Sleep 32: 671–679.

28.

Gau

Chong

Chen

. (2005) A 3-year panel study of mental disorders among adolescents in Taiwan. Am J Psychiatry 162: 1344–1350.

29.

Gau

Chong

Yang

. (2007) Psychiatric and psychosocial predictors of substance use disorders among adolescents: longitudinal study. Br J Psychiay 190: 42–48.

30.

Gau

Shang

(2010) Improvement of executive functions in boys with attention deficit hyperactivity disorder: an open-label follow-up study with once-daily atomoxetine. Int J Neuropsychopharmacol 13: 243–256.

31.

Geurts

Grasman

Verte

. (2008) Intra-individual variability in ADHD, autism spectrum disorders and Tourette’s syndrome. Neuropsychologia 46: 3030–3041.

32.

Gau

Tzang

. (2013) The ex-Gaussian distribution of reaction times in adolescents with attention-deficit/hyperactivity disorder. Res Dev Disabil 34: 3709–3719.

33.

Gualtieri

Wargin

Kanoy

. (1982) Clinical studies of methylphenidate serum levels in children and adults. J Am Acad Child Psychiat 21: 19–26.

34.

Halperin

Trampush

Miller

. (2008) Neuropsychological outcome in adolescents/young adults with childhood ADHD: profiles of persisters, remitters and controls. J Child Psychol Psychiat 49: 958–966.

35.

Hanwella

Senanayake

de Silva

(2011) Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis. BMC Psychiat 11: 176.

36.

Hazell

Kohn

Dickson

. (2011) Core ADHD symptom improvement with atomoxetine versus methylphenidate: a direct comparison meta-analysis. J Atten Disord 15: 674–683.

37.

Heiser

Frey

Smidt

. (2004) Objective measurement of hyperactivity, impulsivity, and inattention in children with hyperkinetic disorders before and after treatment with methylphenidate. Eur Child Adolesc Psychiat 13: 100–104.

38.

Hervey

Epstein

Curry

. (2006) Reaction time distribution analysis of neuropsychological performance in an ADHD sample. Child Neuropsychol 12: 125–140.

39.

Imeraj

Sonuga-Barke

Antrop

. (2012). Altered circadian profiles in attention-deficit/hyperactivity disorder: an integrative review and theoretical framework for future studies. Neurosci Biobehav Rev 36: 1897–1919.

40.

Karalunas

Geurts

Konrad

. (2014) Annual research review: Reaction time variability in ADHD and autism spectrum disorders: measurement and mechanisms of a proposed trans-diagnostic phenotype. J Child Psychol Psychiat 55: 685–710.

41.

Kessler

Adler

Ames

. (2005) The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med 35: 245–256.

42.

Klein

Wendling

Huettner

. (2006) Intra-subject variability in attention-deficit hyperactivity disorder. Biol Psychiat 60: 1088–1097.

43.

Kofler

Rapport

Sarver

. (2013) Reaction time variability in ADHD: a meta-analytic review of 319 studies. Clin Psychol Rev 33: 795–811.

44.

Kollins

McClernon

Epstein

(2009) Effects of smoking abstinence on reaction time variability in smokers with and without ADHD: an ex-Gaussian analysis. Drug Alcohol Depend 100: 169–172.

45.

Kuntsi

Klein

(2012) Intraindividual variability in ADHD and its implications for research of causal links. Curr Top Behav Neurosci 9: 67–91.

46.

Lacouture

Cousineau

(2008) How to use MATLAB to fit the ex-Gaussian and other probability functions to a distribution of response times. Tutorials Quant Meth Psychol 4: 35–45.

47.

Lerman

Loughead

. (2014) Large-scale brain network coupling predicts acute nicotine abstinence effects on craving and cognitive function. JAMA Psychiat 71: 523–530.

48.

Leth-Steensen

Elbaz

Douglas

(2000) Mean response times, variability, and skew in the responding of ADHD children: a response time distributional approach. Acta Psycholog 104: 167–190.

49.

Lin

Gau

(2015) Atomoxetine treatment strengthens an anti-correlated relationship between functional brain networks in medication-naïve adults with attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled clinical trial. Int J Neuropsychopharmacol Epub ahead of print 16 September 2015. DOI: 10.1093/ijnp/pyv094.

50.

Lin

Gau

Huang-Gu

. (2014) Neural substrates of behavioral variability in attention deficit hyperactivity disorder: based on ex-Gaussian reaction time distribution and diffusion spectrum imaging tractography. Psychol Med 44: 1751–1764.

51.

Lin

Hwang-Gu

Gau

(2015) Intra-individual reaction time variability based on ex-Gaussian distribution as a potential endophenotype for attention-deficit/hyperactivity disorder. Acta Psychiatr Scand 132: 39–50.

52.

Luce

(1986) Response times: their role in inferring elementary mental organization, New York: Oxford University Press.

53.

Martin

Guenthner

Bingcang

. (2007) Measurement of the subjective effects of methylphenidate in 11- to 15-year-old children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 17: 63–73.

54.

Menossi

Goudriaan

de Azevedo-Marques Perico

. (2013) Neural bases of pharmacological treatment of nicotine dependence – insights from functional brain imaging: a systematic review. CNS Drugs 27: 921–941.

55.

Michelson

Allen

Busner

. (2002) Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiat 159: 1896–1901.

56.

Nandam

Hester

Wagner

. (2011) Methylphenidate but not atomoxetine or citalopram modulates inhibitory control and response time variability. Biol Psychiat 69: 902–904.

57.

Lin

Gau

. (2013a) An open-label, randomized trial of methylphenidate and atomoxetine treatment in adults with ADHD. J Atten Disord. Epub ahead of print 8 March 2013. DOI:10.1177/1087054713476549.

58.

Shang

Gau

. (2013b) A head-to-head randomized clinical trial of methylphenidate and atomoxetine treatment for executive function in adults with attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol 16: 1959–1973.

59.

Peterson

Potenza

Wang

. (2009) An FMRI study of the effects of psychostimulants on default-mode processing during Stroop task performance in youths with ADHD. Am J Psychiat 166: 1286–1294.

60.

Raymaekers

Antrop

van der Meere

. (2007) HFA and ADHD: a direct comparison on state regulation and response inhibition. J Clin Exp Neuropsychol 29: 418–427.

61.

Rommelse

Altink

Oosterlaan

. (2008) Speed, variability, and timing of motor output in ADHD: which measures are useful for endophenotypic research? Behav Genet 38: 121–132.

62.

Schmidt

Collette

Cajochen

. (2007) A time to think: circadian rhythms in human cognition. Cogn Neuropsychol 24: 755–789.

63.

Schulz

Fan

Bedard

. (2012) Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder. Arch Gen Psychiat 69: 952–961.

64.

Schwartz

Correll

(2014) Efficacy and safety of atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: results from a comprehensive meta-analysis and metaregression. J Am Acad Child Adolesc Psychiat 53: 174–187.

65.

Seidman

(2006) Neuropsychological functioning in people with ADHD across the lifespan. Clin Psychol Rev 26: 466–485.

66.

Shang

Gau

(2012) Improving visual memory, attention, and school function with atomoxetine in boys with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 22: 353–363.

67.

Smith

Cubillo

Barrett

. (2013) Neurofunctional effects of methylphenidate and atomoxetine in boys with attention-deficit/hyperactivity disorder during time discrimination. Biol Psychiat 74: 615–622.

68.

Spencer

Hawk

Jr Richards

. (2009) Stimulant treatment reduces lapses in attention among children with ADHD: the effects of methylphenidate on intra-individual response time distributions. J Abnorm Child Psychol 37: 805–816.

69.

Teicher

Lowen

Polcari

. (2004) Novel strategy for the analysis of CPT data provides new insight into the effects of methylphenidate on attentional states in children with ADHD. J Child Adolesc Psychopharmacol 14: 219–232.

70.

Tseng

Gau

(2013) Executive function as a mediator in the link between attention-deficit/hyperactivity disorder and social problems. J Child Psychol Psychiat 54: 996–1004.

71.

Tucha

Mecklinger

Laufkotter

. (2006) Methylphenidate-induced improvements of various measures of attention in adults with attention deficit hyperactivity disorder. J Neural Transm 113: 1575–1592.

72.

Turner

Blackwell

Dowson

. (2005) Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder. Psychopharmacol (Berl) 178: 286–295.

73.

Uebel

Albrecht

Asherson

. (2010) Performance variability, impulsivity errors and the impact of incentives as gender-independent endophenotypes for ADHD. J Child Psychol Psychiat 51: 210–218.

74.

Ulrich

Miller

(1994) Effects of truncation on reaction time analysis. J Exp Psychol Gen 123: 34–80.

75.

Vaurio

Simmonds

Mostofsky

(2009) Increased intra-individual reaction time variability in attention-deficit/hyperactivity disorder across response inhibition tasks with different cognitive demands. Neuropsychologia 47: 2389–2396.

76.

Wigal

Schuck

. (2011) Academic, behavioral, and cognitive effects of OROS(R) methylphenidate on older children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 21: 121–131.

77.

Gau

(2013) Correlates for academic performance and school functioning among youths with and without persistent attention-deficit/hyperactivity disorder. Res Dev Disabil 34: 505–515.

78.

Yang

Tai

Yang

. (2013) Prediction of childhood ADHD symptoms to quality of life in young adults: adult ADHD and anxiety/depression as mediators. Res Dev Disabil 34: 3168–3181.

79.

Yeh

Gau

Kessler

. (2008) Psychometric properties of the Chinese version of the adult ADHD Self-report Scale. Int J Meth Psych Res 17: 45–54.